Ligand Pharmaceuticals (LGND) Q3 2026 Earnings

6AugConfirmed
Q3 2025
Q4 2025
Q2 2026
Next
1.42
1.98
2.53
3.09

Details

Expected EPS
1.839795
Actual EPS
N/A
Surprise EPS
-1.84
Surprise Percent
+100%

Description

Ligand Pharmaceuticals (LGND) will report earnings of for Q3 2026 on August 06, 2026.

0 Comments

Share your thoughts